Recombinant multi-species CACNG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Voltage-dependent calcium channels are composed of five subunits. The protein encoded by this gene represents one of these subunits, gamma, and is one of two known gamma subunit proteins. This particular gamma subunit is part of skeletal muscle 1,4-dihydropyridine-sensitive calcium channels and is an integral membrane protein that plays a role in excitation-contraction coupling. This gene is part of a functionally diverse eight-member protein subfamily of the PMP-22/EMP/MP20 family and is located in a cluster with two family members that function as transmembrane AMPA receptor regulatory proteins (TARPs). [provided by RefSeq, Dec 2010]
The Alternative Names of target: CACNG1,CACNLG,Cacng,Cacng1,Dihydropyridine-sensitive L-type,Voltage-dependent calcium channel gamma-1 subunit,skeletal muscle calcium channel subunit gamma

Target products collectionGo to CACNG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0491-Ag-1/ GM-Tg-hg-IP0491-Ag-2 Human CACNG1 protein Human
GM-Tg-rg-IP0491-Ag-1/ GM-Tg-rg-IP0491-Ag-2 Rat CACNG1 protein Rat
GM-Tg-mg-IP0491-Ag-1/ GM-Tg-mg-IP0491-Ag-2 Mouse CACNG1 protein Mouse
GM-Tg-cynog-IP0491-Ag-1/ GM-Tg-cynog-IP0491-Ag-2 Cynomolgus/Rhesus macaque CACNG1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0491-Ag-1/ GM-Tg-felg-IP0491-Ag-2 Feline CACNG1 protein Feline
GM-Tg-cang-IP0491-Ag-1/ GM-Tg-cang-IP0491-Ag-2 Canine CACNG1 protein Canine
GM-Tg-bovg-IP0491-Ag-1/ GM-Tg-bovg-IP0491-Ag-2 Bovine CACNG1 protein Bovine
GM-Tg-equg-IP0491-Ag-1/ GM-Tg-equg-IP0491-Ag-2 Equine CACNG1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0491-Ag-1/ GM-Tg-hg-IP0491-Ag-2; GM-Tg-rg-IP0491-Ag-1/ GM-Tg-rg-IP0491-Ag-2;
GM-Tg-mg-IP0491-Ag-1/ GM-Tg-mg-IP0491-Ag-2; GM-Tg-cynog-IP0491-Ag-1/ GM-Tg-cynog-IP0491-Ag-2;
GM-Tg-felg-IP0491-Ag-1/ GM-Tg-felg-IP0491-Ag-2; GM-Tg-cang-IP0491-Ag-1/ GM-Tg-cang-IP0491-Ag-2;
GM-Tg-bovg-IP0491-Ag-1/ GM-Tg-bovg-IP0491-Ag-2; GM-Tg-equg-IP0491-Ag-1/ GM-Tg-equg-IP0491-Ag-2
Products Name CACNG1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CACNG1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CACNG1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.